Companies in the Consumer Goods sector have received a lot of coverage today as analysts weigh in on Prestige Consumer Healthcare (PBH – Research Report) and Beyond Meat (BYND – Research Report).
Prestige Consumer Healthcare (PBH)
In a report released yesterday, Susan Anderson from Canaccord Genuity maintained a Buy rating on Prestige Consumer Healthcare, with a price target of $79.00. The company’s shares closed last Thursday at $59.17.
According to TipRanks.com, Anderson is a 5-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Prestige Consumer Healthcare with a $79.00 average price target.
See the top stocks recommended by analysts >>
Beyond Meat (BYND)
Canaccord Genuity analyst Robert Burleson maintained a Hold rating on Beyond Meat yesterday and set a price target of $7.50. The company’s shares closed last Thursday at $7.00, close to its 52-week low of $5.58.
According to TipRanks.com, Burleson is ranked #728 out of 8565 analysts.
Currently, the analyst consensus on Beyond Meat is a Moderate Sell with an average price target of $6.67.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on PBH:
- Prestige Consumer sees FY24 EPS $4.27-$4.32 , consensus $4.31
- Prestige Consumer reports Q2 EPS $1.07, consensus $1.07
- Prestige Consumer Healthcare Inc. Reports Second Quarter Fiscal 2024 Results
- PBH Earnings this Week: How Will it Perform?
- Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Second Quarter Earnings Results
